Neurogene Inc. (NGNE) stock
NGNENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$23.14+0.04 (+0.17%)
Close on Nov 18, 2026Market cap $463.06MP/E –Yield –
Neurogene price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Neurogene's price to sales ratio was 240.9× on Apr 30, 2025.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Apr 30, 2025 | 240.9× | +230.8 |
| 2019 | Apr 30, 2019 | 10.1× | – |
See a number that looks wrong?